WO1998053760A2 - Locking stent - Google Patents

Locking stent Download PDF

Info

Publication number
WO1998053760A2
WO1998053760A2 PCT/US1998/011449 US9811449W WO9853760A2 WO 1998053760 A2 WO1998053760 A2 WO 1998053760A2 US 9811449 W US9811449 W US 9811449W WO 9853760 A2 WO9853760 A2 WO 9853760A2
Authority
WO
WIPO (PCT)
Prior art keywords
stent
free ends
expanded
struts
expandable
Prior art date
Application number
PCT/US1998/011449
Other languages
French (fr)
Inventor
Jay S. Yadav
Original Assignee
Yadav Jay S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yadav Jay S filed Critical Yadav Jay S
Priority to AU77224/98A priority Critical patent/AU7722498A/en
Publication of WO1998053760A2 publication Critical patent/WO1998053760A2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/958Inflatable balloons for placing stents or stent-grafts

Definitions

  • This invention relates to endoprosthesis devices, generally called stents, and, more particularly, to expandable stents that lock in place once installed within a corporeal lumen .
  • Stents are generally tubular shaped devices that function to hold open a segment of a blood vessel or other anatomical lumen and are useful in the treatment of atherosclerotic stenoses in blood vessels.
  • a wide variety of stents have been developed for treating diseases of the blood vessels and other tubular structures inside the body. Stents are particularly suitable for use in supporting and holding back a dissected arterial lining that can occlude the fluid passageway therethrough.
  • stents In order to accomplish precise placement of stents within a corporeal lumen and to ensure that a stent placed at a particular position within a body remains at that position, various means are employed.
  • the currently available stents fall within two broad categories: balloon expandable and self-expanding.
  • a balloon expandable stent is attached onto the outside of an uninflated balloon, which is then introduced into the body vessel and expanded at the desired stent location, thereby also expanding the stent being carried by the balloon.
  • the balloon is then deflated, leaving the expanded stent in place within the vessel.
  • Balloon expandable stents have the advantage of being expandable to the exact diameter of the vessel into which they are being introduced, thus allowing for precise sizing. However, these stents are susceptible to external compression after implantation that can lead to loss of rigidity of the stent and perhaps even collapsing.
  • a self-expanding stent which generally has an expanded stent position as its relaxed state, is introduced in a collapsed state into the body vessel and, upon triggering or release of a particular mechanism, is allowed to expand into its expanded, relaxed position.
  • Self-expanding stents are less susceptible to external compression but will expand only to a preset diameter. If the stent is undersized in comparison to the host vessel, the risk of stent migration within the vessel exists. Oversizing the stent relative to the host vessel, in order to ensure that the stent remains in place within the vessel, unfortunately increases the trauma to the vessel wall.
  • An ideal stent would have the precise sizing capabilities of the balloon-expandable stents and the compression resistance of the self-expanding stents.
  • U.S. Patent No. 5,423,885 shows an expandable, balloon intravascular stent that resists collapsing to a smaller diameter once it has been expanded to a larger diameter.
  • the Williams stent is prevented from collapsing due to a plurality of protrusions on its outer surface that engage the walls of the artery or vessel into which it is disposed, thereby locking the stent in the larger diameter.
  • This stent thus avoids radial collapse and axial displacement of the stent by use of protrusions that are anchored into the walls of the host vessel.
  • This stent has the severe drawback of causing trauma and potential damage to the host vessel wall. It is desirable to provide a stent that will achieve these results without damaging the walls of the host vessel.
  • the present invention is directed to providing a stent, adapted to be attached or implanted with a body vessel, that is designed to expand through use of a balloon catheter or some other means and to remain in the expanded state with an enlarged diameter by engaging of locking teeth on overlapping segments of longitudinally extending segments of the stent structure.
  • the stent is formed by a truss structure, part of which has triangular segments with longitudinally-extending bases.
  • the stent has a plurality of teeth or angled protrusions on the overlapping segments of the bases of the triangles that engage each other during expansion of the stent and prevent the stent from collapsing beyond the diameter already achieved.
  • FIG. 1 shows a side elevational view of a balloon- expandable stent structure in accordance with an embodiment of this invention in an unexpanded position about an uninflated balloon;
  • FIG. 2 shows a side elevational view of the balloon- expandable stent structure of this invention in an expanded position about an inflated balloon
  • FIG. 3 shows a close-up side elevational view of the locking portion of the balloon-expandable stent structure of this invention
  • FIG. 4 shows a cross-sectional view of the locking portion of the balloon-expandable stent structure of this invention.
  • a balloon-expandable stent structure 1 is formed in a generally tubular or cylindrical shape with an opening 2 at each stent end.
  • stent 1 can be constructed of a variety of metallic or non-metallic alloys. The composition of the alloy of stent 1 is geared to provide strength and rigidity. Other compositions of stent 1 can be used without departing from the principles of this invention.
  • stent 1 is constructed of struts 5 that intersect, interconnect and interlock in a truss structure format in order to provide rigidity during its expanded shape within the body vessel .
  • One fundamental geometrical structural sub-unit of stent 1 is the triangle, since it is believed to be among the most rigid of the geometrical shapes.
  • stent 1 is formed with triangle substructures 6,7,8,9 as some of its rigid support units.
  • the bases 10,11,12,13 of triangle substructures 6-9 will lock relative to each other during expansion of stent 1 so that stent 1 is locked in its expanded shape.
  • FIG. 1 shows stent 1 in its collapsed state about the distal end of an uninflated balloon 3 of a balloon catheter 4. In its collapsed state, stent 1 has a relatively smaller diameter and a larger length that it does in its expanded state shown in FIG. 2.
  • Bases 10-13 of triangle substructures 6-9 which lie in a longitudinal direction relative to stent 1, are formed by overlapping members 10'- 13' and 10" -13". The ends of members 10' -13' and 10" -13" are separated during the collapsed state of stent 1 but, as will be discussed below, join with a slight overlap as bases 10-13 of triangles 6-9 shorten during stent expansion.
  • the terminal adjacent surfaces of longitudinally-extending, overlapping members 10' -13' and 10"-13" are provided with small ridges or angled teeth 20,21 that face in opposing directions so as to allow relatively easy passage of the ends relative to each other in one direction, i.e., to allow overlapping.
  • these same teeth 20,21 prevent separation of the ends once overlapping has occurred.
  • balloon 3, carrying stent 1 is then introduced into the body vessel at the distal end of balloon catheter 4 and is expanded at the desired stent location, thereby also expanding stent 1 which is carried by balloon 3, as shown in FIG. 2.
  • Expansion of stent 1 causes bases 10-13 of triangle substructures 6-9 to shorten correspondingly, thereby causing the ends of members 10' -13' and 10"-13" to move towards each other in the direction of arrows A and B, respectively, into an overlapping relationship, as illustrated in FIG. 3. Movement of the ends of members 10'- 13' and 10 "-13" in the respective direction of arrows A and B is permitted due to the angles of teeth 20,21.
  • Balloon 3 is then deflated, leaving stent 1 in its expanded state in place within the vessel. Further expansion (increase in the radius of curvature) of stent 1 would be possible, as the ends of members 10' -13' and 10 "-13" move further towards each other in the direction of arrows A and B, respectively, into a further overlapping relationship. However, collapse (decrease in the radius of curvature) of stent 1 would be prevented by the fact that teeth 20,21 engage with each other and do not permit movement u> to t P> H o in ⁇ ⁇ o in

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Prostheses (AREA)

Abstract

An expandable intraluminal stent able to resist axial compression, comprising a body portion having a generally cylindrical structure formed by a series of interconnected bars or struts, at least one of said struts being formed of two portions having overlapping free ends; and a plurality of teeth projecting on adjacent surfaces of said overlapping free ends; whereby said stent is expanded to allow said two portions of said at least one strut to overlap at said free ends, whereby said teeth on said adjacent surfaces of said overlapping free ends of said struts engage one another to retain said stent in its expanded shape.

Description

LOCKING STENT
FIELD OF THE INVENTION
This invention relates to endoprosthesis devices, generally called stents, and, more particularly, to expandable stents that lock in place once installed within a corporeal lumen .
BACKGROUND OF THE INVENTION
Stents are generally tubular shaped devices that function to hold open a segment of a blood vessel or other anatomical lumen and are useful in the treatment of atherosclerotic stenoses in blood vessels. A wide variety of stents have been developed for treating diseases of the blood vessels and other tubular structures inside the body. Stents are particularly suitable for use in supporting and holding back a dissected arterial lining that can occlude the fluid passageway therethrough.
In order to accomplish precise placement of stents within a corporeal lumen and to ensure that a stent placed at a particular position within a body remains at that position, various means are employed. The currently available stents fall within two broad categories: balloon expandable and self-expanding.
A balloon expandable stent is attached onto the outside of an uninflated balloon, which is then introduced into the body vessel and expanded at the desired stent location, thereby also expanding the stent being carried by the balloon. The balloon is then deflated, leaving the expanded stent in place within the vessel. Balloon expandable stents have the advantage of being expandable to the exact diameter of the vessel into which they are being introduced, thus allowing for precise sizing. However, these stents are susceptible to external compression after implantation that can lead to loss of rigidity of the stent and perhaps even collapsing. A self-expanding stent, which generally has an expanded stent position as its relaxed state, is introduced in a collapsed state into the body vessel and, upon triggering or release of a particular mechanism, is allowed to expand into its expanded, relaxed position. Self-expanding stents, on the other hand, are less susceptible to external compression but will expand only to a preset diameter. If the stent is undersized in comparison to the host vessel, the risk of stent migration within the vessel exists. Oversizing the stent relative to the host vessel, in order to ensure that the stent remains in place within the vessel, unfortunately increases the trauma to the vessel wall.
An ideal stent would have the precise sizing capabilities of the balloon-expandable stents and the compression resistance of the self-expanding stents.
U.S. Patent No. 5,423,885 (Williams) shows an expandable, balloon intravascular stent that resists collapsing to a smaller diameter once it has been expanded to a larger diameter. However, the Williams stent is prevented from collapsing due to a plurality of protrusions on its outer surface that engage the walls of the artery or vessel into which it is disposed, thereby locking the stent in the larger diameter. This stent thus avoids radial collapse and axial displacement of the stent by use of protrusions that are anchored into the walls of the host vessel. This stent has the severe drawback of causing trauma and potential damage to the host vessel wall. It is desirable to provide a stent that will achieve these results without damaging the walls of the host vessel.
OBJECTS OF THE INVENTION
It is an object of this invention to provide an improved stent .
It is also an object of this invention to provide stents with precise sizing capabilities. It is a further object of this invention to provide stents that are compression resistant.
It is another object of this invention to provide stents that lock in an expanded shape once expanded. These and other objects of the invention will become more apparent in the discussion below.
SUMMARY OF THE INVENTION
The present invention is directed to providing a stent, adapted to be attached or implanted with a body vessel, that is designed to expand through use of a balloon catheter or some other means and to remain in the expanded state with an enlarged diameter by engaging of locking teeth on overlapping segments of longitudinally extending segments of the stent structure. The stent is formed by a truss structure, part of which has triangular segments with longitudinally-extending bases. The stent has a plurality of teeth or angled protrusions on the overlapping segments of the bases of the triangles that engage each other during expansion of the stent and prevent the stent from collapsing beyond the diameter already achieved.
BRIEF DESCRIPTION OF THE DRAWINGS
The above and other objects and advantages of the invention will be apparent upon consideration of the following detailed description, taken in conjunction with the accompanying drawings, in which the reference characters refer to like parts throughout and in which:
FIG. 1 shows a side elevational view of a balloon- expandable stent structure in accordance with an embodiment of this invention in an unexpanded position about an uninflated balloon;
FIG. 2 shows a side elevational view of the balloon- expandable stent structure of this invention in an expanded position about an inflated balloon; FIG. 3 shows a close-up side elevational view of the locking portion of the balloon-expandable stent structure of this invention; and
FIG. 4 shows a cross-sectional view of the locking portion of the balloon-expandable stent structure of this invention.
DETAILED DESCRIPTION OF THE INVENTION
This invention can perhaps be better appreciated by making reference to the drawings. In this invention, as illustrated in FIG. 1, a balloon-expandable stent structure 1 is formed in a generally tubular or cylindrical shape with an opening 2 at each stent end. In a preferred embodiment of the invention, stent 1 can be constructed of a variety of metallic or non-metallic alloys. The composition of the alloy of stent 1 is geared to provide strength and rigidity. Other compositions of stent 1 can be used without departing from the principles of this invention.
In the preferred embodiment of this invention, stent 1 is constructed of struts 5 that intersect, interconnect and interlock in a truss structure format in order to provide rigidity during its expanded shape within the body vessel . One fundamental geometrical structural sub-unit of stent 1 is the triangle, since it is believed to be among the most rigid of the geometrical shapes. As shown in FIG. 1, stent 1 is formed with triangle substructures 6,7,8,9 as some of its rigid support units. As will be described herein, the bases 10,11,12,13 of triangle substructures 6-9 will lock relative to each other during expansion of stent 1 so that stent 1 is locked in its expanded shape.
As illustrated in FIG. 1, bars 5 of stent 1 are generally interconnected to form a truss-like structure for stent 1. FIG. 1 shows stent 1 in its collapsed state about the distal end of an uninflated balloon 3 of a balloon catheter 4. In its collapsed state, stent 1 has a relatively smaller diameter and a larger length that it does in its expanded state shown in FIG. 2. Bases 10-13 of triangle substructures 6-9, which lie in a longitudinal direction relative to stent 1, are formed by overlapping members 10'- 13' and 10" -13". The ends of members 10' -13' and 10" -13" are separated during the collapsed state of stent 1 but, as will be discussed below, join with a slight overlap as bases 10-13 of triangles 6-9 shorten during stent expansion.
As illustrated in FIGS.- 3 and 4, the terminal adjacent surfaces of longitudinally-extending, overlapping members 10' -13' and 10"-13" are provided with small ridges or angled teeth 20,21 that face in opposing directions so as to allow relatively easy passage of the ends relative to each other in one direction, i.e., to allow overlapping. However, these same teeth 20,21 prevent separation of the ends once overlapping has occurred.
Typically, balloon 3, carrying stent 1, is then introduced into the body vessel at the distal end of balloon catheter 4 and is expanded at the desired stent location, thereby also expanding stent 1 which is carried by balloon 3, as shown in FIG. 2. Expansion of stent 1 causes bases 10-13 of triangle substructures 6-9 to shorten correspondingly, thereby causing the ends of members 10' -13' and 10"-13" to move towards each other in the direction of arrows A and B, respectively, into an overlapping relationship, as illustrated in FIG. 3. Movement of the ends of members 10'- 13' and 10 "-13" in the respective direction of arrows A and B is permitted due to the angles of teeth 20,21. Balloon 3 is then deflated, leaving stent 1 in its expanded state in place within the vessel. Further expansion (increase in the radius of curvature) of stent 1 would be possible, as the ends of members 10' -13' and 10 "-13" move further towards each other in the direction of arrows A and B, respectively, into a further overlapping relationship. However, collapse (decrease in the radius of curvature) of stent 1 would be prevented by the fact that teeth 20,21 engage with each other and do not permit movement u> to t P> H o in σ υι o in
P-
0
< φ
0 rt
P-
O
0 rt
P β ιp tr rt ø-
Φ
H
Φ
I
I
Figure imgf000008_0001

Claims

I CLAIM :
1. An expandable intraluminal stent able to resist axial compression, comprising: a body portion having a generally cylindrical structure formed by a series of interconnected bars or struts, at least one of said struts being formed of two portions having overlapping free ends; and a plurality of teeth projecting on adjacent surfaces of said overlapping free ends; whereby said stent is expanded to allow said two portions of said at least one strut to overlap at said free ends, whereby said teeth on said adjacent surfaces of said overlapping free ends of said struts engage one another to retain said stent in its expanded shape.
2. The expandable stent of claim 1 wherein said stent is capable of being carried into a vessel in a collapsed state on a balloon catheter and expanded thereby into an expanded state .
3. The expandable stent of claim 1 wherein at least some of said interconnecting struts form a triangular substructure having a base strut and two angled struts, wherein said base strut of said triangular sub-structure is formed of two portions having overlapping free ends.
4. The expandable stent of claim 2 wherein said base strut extends longitudinally with respect to said cylindrical structure of said stent .
PCT/US1998/011449 1997-05-28 1998-05-28 Locking stent WO1998053760A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU77224/98A AU7722498A (en) 1997-05-28 1998-05-28 Locking stent

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60/047,99 1997-05-28
US479997 1997-05-28

Publications (1)

Publication Number Publication Date
WO1998053760A2 true WO1998053760A2 (en) 1998-12-03

Family

ID=21712589

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/011449 WO1998053760A2 (en) 1997-05-28 1998-05-28 Locking stent

Country Status (2)

Country Link
AU (1) AU7722498A (en)
WO (1) WO1998053760A2 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887266B2 (en) * 2002-11-14 2005-05-03 Synecor, Llc Endoprostheses and methods of manufacture
EP1567099A2 (en) * 2002-11-15 2005-08-31 Synecor, LLC Improved endoprostheses and methods of manufacture
WO2006052574A2 (en) * 2004-11-04 2006-05-18 Boston Scientific Limited (Barbados Home Office) Stent for delivering a therapeutic agent
US7704276B2 (en) * 2002-11-15 2010-04-27 Synecor, Llc Endoprostheses and methods of manufacture
EP2438872A1 (en) * 2010-10-08 2012-04-11 Biotronik AG Medical implant, in particular a stent, for implantation in an animal body and/or human body
CN105796208A (en) * 2016-03-09 2016-07-27 北京工业大学 Vascular stent with circumferential supporting bars
EP2768429B1 (en) 2011-10-21 2018-05-09 Syntheon TAVR, LLC Actively controllable stent, stent graft, heart valve
US10568732B2 (en) 2009-07-02 2020-02-25 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US10687968B2 (en) 2006-07-31 2020-06-23 Edwards Lifesciences Cardiaq Llc Sealable endovascular implants and methods for their use
US10874508B2 (en) 2011-10-21 2020-12-29 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US10980650B2 (en) 2011-10-21 2021-04-20 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US11540911B2 (en) 2010-12-29 2023-01-03 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887266B2 (en) * 2002-11-14 2005-05-03 Synecor, Llc Endoprostheses and methods of manufacture
US7704276B2 (en) * 2002-11-15 2010-04-27 Synecor, Llc Endoprostheses and methods of manufacture
AU2003285194B2 (en) * 2002-11-15 2007-08-09 Synecor, Llc Endoprostheses and methods of manufacture
EP1567099A4 (en) * 2002-11-15 2011-03-30 Synecor Llc Improved endoprostheses and methods of manufacture
EP1567099A2 (en) * 2002-11-15 2005-08-31 Synecor, LLC Improved endoprostheses and methods of manufacture
WO2006052574A2 (en) * 2004-11-04 2006-05-18 Boston Scientific Limited (Barbados Home Office) Stent for delivering a therapeutic agent
WO2006052574A3 (en) * 2004-11-04 2006-09-14 Boston Scient Scimed Inc Stent for delivering a therapeutic agent
US7628807B2 (en) 2004-11-04 2009-12-08 Boston Scientific Scimed, Inc. Stent for delivering a therapeutic agent having increased body tissue contact surface
US10925760B2 (en) 2006-07-31 2021-02-23 Edwards Lifesciences Cardiaq Llc Sealable endovascular implants and methods for their use
US11877941B2 (en) 2006-07-31 2024-01-23 Edwards Lifesciences Cardiaq Llc Sealable endovascular implants and methods for their use
US10687968B2 (en) 2006-07-31 2020-06-23 Edwards Lifesciences Cardiaq Llc Sealable endovascular implants and methods for their use
US10568732B2 (en) 2009-07-02 2020-02-25 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US11766323B2 (en) 2009-07-02 2023-09-26 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
EP2438872A1 (en) * 2010-10-08 2012-04-11 Biotronik AG Medical implant, in particular a stent, for implantation in an animal body and/or human body
US8647378B2 (en) 2010-10-08 2014-02-11 Biotronik Ag Medical implant, in particular a stent, for implantation in an animal body and/or human body
US11540911B2 (en) 2010-12-29 2023-01-03 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US10874508B2 (en) 2011-10-21 2020-12-29 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US10980650B2 (en) 2011-10-21 2021-04-20 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
EP2768429B2 (en) 2011-10-21 2022-04-06 Syntheon TAVR, LLC Actively controllable stent, stent graft, heart valve
US10478295B2 (en) 2011-10-21 2019-11-19 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US11707356B2 (en) 2011-10-21 2023-07-25 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
EP2768429B1 (en) 2011-10-21 2018-05-09 Syntheon TAVR, LLC Actively controllable stent, stent graft, heart valve
CN105796208A (en) * 2016-03-09 2016-07-27 北京工业大学 Vascular stent with circumferential supporting bars

Also Published As

Publication number Publication date
AU7722498A (en) 1998-12-30

Similar Documents

Publication Publication Date Title
US6083258A (en) Locking stent
US6027526A (en) Stent having varied amounts of structural strength along its length
AU2005282354B2 (en) Optimized flex link for expandable stent
US6293964B1 (en) Ostial stent
EP1021140B1 (en) Compliant intraluminal stents
US7867272B2 (en) Stent having twist cancellation geometry
EP1819300B1 (en) Stent having phased hoop sections
JPH11501526A (en) Endoluminal stent
US20030074051A1 (en) Flexible stent
WO1998017204A2 (en) Locking stent
JP2002509760A (en) Expandable unit cells and intraluminal stents
JPH11509754A (en) Expandable stent
US7578840B2 (en) Stent with reduced profile
JP2011504780A (en) Lumen prosthesis
WO1998053760A2 (en) Locking stent
EP1148844A1 (en) Expandable endovascular medical tubular stent
CA2586095C (en) Stent having twist cancellation geometry
AU727751B2 (en) Stent having varied amounts of structural strength along its length
AU2012202185A1 (en) Stent having phased hoop sections

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct app. not ent. europ. phase
NENP Non-entry into the national phase in:

Ref country code: CA

NENP Non-entry into the national phase in:

Ref country code: JP

Ref document number: 1999501044

Format of ref document f/p: F